Xylem Inc. is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment. It has three business segments, which include Water Infrastructure, Applied Water and Sensus. Water Infrastructure focuses on the transportation, treatment and testing of water, offering a range of products, including water and wastewater pumps, and controls and systems. Applied Water serves the uses of water and focuses on the residential, commercial, industrial and agricultural markets. The Sensus segment's products include metering, networked communications, measurement and control technologies, software and services, including cloud-based analytics, remote monitoring and data management.
Industry, Sector and Symbol:
- Sector: Industrial Products
- Industry: Pump & Pumping Equipment
- Sub-Industry: Industrial Machinery
- Symbol: NYSE:XYL
- CUSIP: 98419M10
- Web: www.xyleminc.com
- Market Cap: $11.5 billion
- Outstanding Shares: 179,568,000
- 50 Day Moving Avg: $60.96
- 200 Day Moving Avg: $54.45
- 52 Week Range: $45.60 - $64.49
Sales & Book Value:
- Trailing P/E Ratio: 41.33
- Foreward P/E Ratio: 23.54
- P/E Growth: 1.98
- Annual Revenue: $4.23 billion
- Price / Sales: 2.72
- Book Value: $13.18 per share
- Price / Book: 4.86
- Annual Dividend: $0.72
- Dividend Yield: 1.1%
- EBIDTA: $723 million
- Net Margins: 6.58%
- Return on Equity: 17.26%
- Return on Assets: 6.40%
- Debt-to-Equity Ratio: 0.91%
- Current Ratio: 1.63%
- Quick Ratio: 1.17%
- Average Volume: 1.04 million shs.
- Beta: 1.17
- Short Ratio: 4.54
Frequently Asked Questions for Xylem (NYSE:XYL)
What is Xylem's stock symbol?
Xylem trades on the New York Stock Exchange (NYSE) under the ticker symbol "XYL."
How often does Xylem pay dividends? What is the dividend yield for Xylem?
Xylem announced a quarterly dividend on Thursday, August 17th. Shareholders of record on Thursday, August 31st will be paid a dividend of $0.18 per share on Wednesday, September 20th. This represents a $0.72 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date of this dividend is Tuesday, August 29th. View Xylem's Dividend History.
How were Xylem's earnings last quarter?
Xylem Inc. (NYSE:XYL) issued its quarterly earnings results on Tuesday, August, 1st. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.02. The firm earned $1.16 billion during the quarter, compared to the consensus estimate of $1.17 billion. Xylem had a net margin of 6.58% and a return on equity of 17.26%. The firm's quarterly revenue was up 24.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.48 EPS. View Xylem's Earnings History.
When will Xylem make its next earnings announcement?
What guidance has Xylem issued on next quarter's earnings?
Xylem updated its FY17 earnings guidance on Tuesday, August, 1st. The company provided EPS guidance of $2.30-2.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.31. The company issued revenue guidance of $4.65-4.70 billion, compared to the consensus revenue estimate of $4.60 billion.
Where is Xylem's stock going? Where will Xylem's stock price be in 2017?
13 equities research analysts have issued twelve-month price objectives for Xylem's shares. Their forecasts range from $50.00 to $70.00. On average, they expect Xylem's stock price to reach $59.45 in the next year. View Analyst Ratings for Xylem.
What are analysts saying about Xylem stock?
Here are some recent quotes from research analysts about Xylem stock:
- 1. According to Zacks Investment Research, "Over the last three months, Xylem's shares outperformed the Zacks categorized Machinery-General Industrial industry. Robust demand, greater innovation, increased end-market exposure and higher infrastructure spending of the government authorities in emerging countries (like India) are expected to bolster the company's revenues in the quarters ahead. In addition, solid top-line performances, greater productivity and increased cost discipline are likely to boost the company's profitability moving ahead. Notably, the company's strategic business buyouts are also anticipated to help in strengthening results in the quarters ahead. Over the last 60 days, the Zacks Consensus Estimate for the stock moved north for both 2017 and 2018, highlighting positive sentiments." (7/4/2017)
- 2. Cowen and Company analysts commented, "The April 4 Investor Day is likely an opportunity to dig in to Sensus cost/revenue synergies and recent discussions with customers on a truly unique total offering. We believe FY17/18 consensus is achievable despite some market concern that has affected the stock recently. Medium-term margin upside as Sensus is integrated and core business efficiency work continues. New $60 PT (up from $56)." (3/24/2017)
Who are some of Xylem's key competitors?
Some companies that are related to Xylem include Ingersoll-Rand PLC (Ireland) (IR), Rockwell Automation (ROK), Sandvik AB (SDVKY), Tenaris S.A. (TS), Toray Industries (TRYIY), Norsk Hydro ASA (NHYDY), Cintas Corporation (CTAS), Ball Corporation (BLL), Dover Corporation (DOV), Pentair PLC. (PNR), Packaging Corporation of America (PKG), Smith (A.O.) Corporation (AOS), Fortune Brands Home & Security (FBHS), W.W. Grainger (GWW), AB SKF (SKFRY), IDEX Corporation (IEX), Avery Dennison Corporation (AVY) and Alcoa Corp. (AA).
Who are Xylem's key executives?
Xylem's management team includes the folowing people:
- Markos I. Tambakeras I, Independent Chairman of the Board
- Patrick K. Decker, President, Chief Executive Officer, Director
- E. Mark Rajkowski, Chief Financial Officer, Senior Vice President
- Kairus K. Tarapore, Chief Human Resource Officer, Senior Vice President
- Claudia S. Toussaint, Senior Vice President, General Counsel, Corporate Secretary
- D. Randall Bays, Senior Vice President and President - Sensus
- Tomas Brannemo, Senior Vice President and President - Transport
- David Flinton, Senior Vice President, President - Dewatering
- Pak Steven Leung, Senior Vice President and President - Emerging Markets
- Kenneth Napolitano, Senior Vice President, President - Applied Water Systems
Who owns Xylem stock?
Xylem's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.86%), BlackRock Inc. (6.69%), State Street Corp (4.66%), Pictet Asset Management Ltd. (2.42%), FMR LLC (1.80%) and Gamco Investors INC. ET AL (1.74%). Company insiders that own Xylem stock include Claudia S Toussaint, Colin R Sabol, Kenneth Napolitano, Markos I Tambakeras, Steven R Loranger and Tomas Brannemo. View Institutional Ownership Trends for Xylem.
Who sold Xylem stock? Who is selling Xylem stock?
Xylem's stock was sold by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Mutual of America Capital Management LLC, JPMorgan Chase & Co., Russell Investments Group Ltd., First Trust Advisors LP, Gamco Investors INC. ET AL, Gabelli Funds LLC and Bank of New York Mellon Corp. Company insiders that have sold Xylem stock in the last year include Claudia S Toussaint, Kenneth Napolitano, Steven R Loranger and Tomas Brannemo. View Insider Buying and Selling for Xylem.
Who bought Xylem stock? Who is buying Xylem stock?
Xylem's stock was purchased by a variety of institutional investors in the last quarter, including USS Investment Management Ltd, Janus Henderson Group PLC, Voya Investment Management LLC, William Blair Investment Management LLC, State Street Corp, PointState Capital LP, TD Asset Management Inc. and Chilton Investment Co. LLC. View Insider Buying and Selling for Xylem.
How do I buy Xylem stock?
Shares of Xylem can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Xylem's stock price today?
MarketBeat Community Rating for Xylem (NYSE XYL)MarketBeat's community ratings are surveys of what our community members think about Xylem and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Xylem stock can currently be purchased for approximately $64.04.
Consensus Ratings for Xylem (NYSE:XYL) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||4 Hold Ratings, 9 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.69)|
|Consensus Price Target: ||$59.45 (7.16% downside)|
Analysts' Ratings History for Xylem (NYSE:XYL)
(Data available from 9/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|9/5/2017||Boenning Scattergood||Reiterated Rating||Outperform||Medium|
|9/5/2017||Stifel Nicolaus||Reiterated Rating||Hold||$63.00||Medium|
|8/9/2017||Cowen and Company||Reiterated Rating||Outperform||$60.00 -> $70.00||Low|
|8/2/2017||BMO Capital Markets||Boost Price Target||Outperform||$60.00 -> $65.00||Low|
|8/2/2017||Oppenheimer Holdings, Inc.||Boost Price Target||Outperform||$60.00 -> $66.00||Low|
|8/2/2017||Royal Bank Of Canada||Boost Price Target||Outperform -> Outperform||$58.00 -> $64.00||Low|
|7/28/2017||Canaccord Genuity||Reiterated Rating||Hold||$50.00||Low|
|5/15/2017||Barclays PLC||Upgrade||Equal Weight -> Overweight||$51.00 -> $59.00||High|
|3/8/2017||Goldman Sachs Group, Inc. (The)||Initiated Coverage||Neutral -> Neutral||$52.00||High|
|2/1/2017||Gabelli||Downgrade||Buy -> Hold||N/A|
|11/17/2016||Northcoast Research||Initiated Coverage||Buy||N/A|
|11/2/2016||Janney Montgomery Scott||Upgrade||Neutral -> Buy||$50.00 -> $52.00||N/A|
|8/22/2016||Atlantic Securities||Upgrade||Neutral -> Overweight||$54.00||N/A|
|5/4/2016||Wedbush||Boost Price Target||Neutral||$41.00 -> $43.00||N/A|
|4/5/2016||Sterne Agee CRT||Upgrade||Neutral -> Buy||N/A|
|4/1/2016||Robert W. Baird||Reiterated Rating||Hold||N/A|
|2/5/2016||DA Davidson||Boost Price Target||Neutral||$38.00||N/A|
|1/21/2016||Susquehanna Bancshares Inc||Lower Price Target||$38.00 -> $37.00||N/A|
|1/21/2016||Seaport Global Securities||Upgrade||Accumulate -> Buy||$40.00||N/A|
Earnings History for Xylem (NYSE:XYL)Earnings History by Quarter for Xylem (NYSE XYL)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/1/2017||Q2 2017||$0.57||$0.59||$1.17 billion||$1.16 billion||View||Listen|
|5/2/2017||Q1 2017||$0.38||$0.39||$1.05 billion||$1.07 billion||View||Listen|
|2/2/2017||Q416||$0.65||$0.66||$1.13 billion||$1.10 billion||View||Listen|
|11/1/2016||Q316||$0.53||$0.54||$913.53 million||$897.00 million||View||Listen|
|8/2/2016||Q216||$0.47||$0.48||$927.69 million||$932.00 million||View||Listen|
|5/3/2016||Q116||$0.34||$0.35||$832.03 million||$847.00 million||View||Listen|
|2/4/2016||Q415||$0.60||$0.60||$997.15 million||$994.00 million||View||Listen|
|10/29/2015||Q315||$0.48||$0.49||$897.80 million||$902.00 million||View||Listen|
|7/30/2015||Q215||$0.43||$0.43||$924.98 million||$920.00 million||View||Listen|
|4/30/2015||Q115||$0.31||$0.33||$840.60 million||$837.00 million||View||Listen|
|2/5/2015||Q414||$0.61||$0.62||$1.03 billion||$1.04 billion||View||Listen|
|10/28/2014||Q3||$0.52||$0.53||$982.10 million||$963.00 million||View||Listen|
|7/29/2014||Q214||$0.46||$0.48||$994.85 million||$1.01 billion||View||Listen|
|4/29/2014||Q114||$0.32||$0.34||$888.90 million||$906.00 million||View||Listen|
|2/4/2014||Q413||$0.36||$0.56||$920.07 million||$1.03 billion||View||Listen|
|10/29/2013||Q313||$0.36||$0.49||$918.70 million||$965.00 million||View||Listen|
|7/30/2013||Q2 2013||$0.44||$0.36||$967.90 million||$960.00 million||View||Listen|
|4/30/2013||Q1 2013||$0.28||$0.27||$893.56 million||$879.00 million||View||Listen|
|2/7/2013||Q4 2012||$0.46||$0.47||$980.57 million||$969.00 million||View||Listen|
|11/1/2012||Q312||$0.43||$0.44||$924.00 million||$931.00 million||View||N/A|
Earnings Estimates for Xylem (NYSE:XYL)
2017 EPS Consensus Estimate: $2.32
2018 EPS Consensus Estimate: $2.74
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for Xylem (NYSE:XYL)
|Most Recent Dividend:||9/20/2017|
|Dividend Growth:||-0.10% (3 Year Average)|
|Payout Ratio:||46.45% (Trailing 12 Months of Earnings) |
30.38% (Based on This Year's Estimates)
26.47% (Based on Next Year's Estimates)
|Track Record:||4 Years of Consecutive Dividend Growth|
Dividend History by Quarter for Xylem (NYSE XYL)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Xylem (NYSE:XYL)
Insider Ownership Percentage: 0.75%Insider Trades by Quarter for Xylem (NYSE:XYL)
Institutional Ownership Percentage: 86.43%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/9/2017||Kenneth Napolitano||Insider||Sell||9,052||$60.16||$544,568.32|| |
|6/29/2017||Steven R Loranger||Director||Sell||66,132||$55.01||$3,637,921.32|| |
|5/4/2017||Tomas Brannemo||Insider||Sell||14,080||$50.36||$709,068.80|| |
|2/28/2017||Tomas Brannemo||Insider||Sell||819||$48.46||$39,688.74|| |
|11/4/2016||Claudia S Toussaint||SVP||Sell||5,300||$47.27||$250,531.00|| |
|9/8/2016||Colin R Sabol||Insider||Sell||27,473||$50.91||$1,398,650.43|| |
|8/17/2016||Tomas Brannemo||Insider||Sell||8,524||$50.06||$426,711.44|| |
|8/11/2016||Steven R Loranger||Director||Sell||33,887||$48.11||$1,630,303.57|| |
|7/28/2016||Steven R Loranger||Director||Sell||32,246||$48.01||$1,548,130.46|| |
|6/1/2016||Steven R Loranger||Director||Sell||50,000||$44.52||$2,226,000.00|| |
|5/27/2016||Steven R Loranger||Director||Sell||50,000||$44.67||$2,233,500.00|| |
|5/12/2016||Colin R Sabol||SVP||Sell||39,265||$42.91||$1,684,861.15|| |
|5/5/2016||Kenneth Napolitano||SVP||Sell||10,246||$41.58||$426,028.68|| |
|3/9/2016||Tomas Brannemo||SVP||Sell||7,964||$38.03||$302,870.92|| |
|11/12/2015||Markos I. Tambakeras||Director||Sell||2,025||$36.73||$74,378.25|| |
|11/5/2015||Steven R. Loranger||Director||Sell||165,690||$36.69||$6,079,166.10|| |
|5/29/2015||Colin R Sabol||SVP||Sell||20,712||$36.57||$757,437.84|| |
|5/4/2015||Michael T Speetzen||CFO||Sell||18,000||$36.82||$662,760.00|| |
|3/13/2015||Colin R Sabol||SVP||Sell||20,000||$34.61||$692,200.00|| |
|3/9/2015||Robyn T Mingle||SVP||Sell||27,105||$35.34||$957,890.70|| |
|3/3/2015||Kenneth Napolitano||SVP||Sell||9,859||$36.13||$356,205.67|| |
|3/2/2015||Markos I Tambakeras||Director||Sell||2,454||$36.16||$88,736.64|| |
|11/25/2014||Surya N Mohapatra||Director||Sell||3,640||$38.24||$139,193.60|| |
|11/20/2014||Robyn T Mingle||SVP||Sell||24,298||$37.41||$908,988.18|| |
|11/12/2014||Steven R Loranger||Director||Sell||100,000||$37.51||$3,751,000.00|| |
|3/7/2014||Colin Sabol||SVP||Sell||29,835||$38.47||$1,147,752.45|| |
|2/21/2014||Michael Speetzen||CFO||Sell||61,326||$38.87||$2,383,741.62|| |
|2/19/2014||Curtis Crawford||Director||Sell||5,660||$38.53||$218,079.80|| |
|2/19/2014||John Connolly||CAO||Sell||8,186||$37.62||$307,957.32|| |
|2/11/2014||Markos Tambakeras||Director||Sell||2,373||$37.23||$88,346.79|| |
|2/7/2014||Kenneth Napolitano||SVP||Sell||28,846||$36.79||$1,061,244.34|| |
|2/6/2014||Angela Buonocore||SVP||Sell||11,996||$36.00||$431,856.00|| |
|1/15/2014||Steven Loranger||CEO||Sell||89,235||$36.08||$3,219,598.80|| |
|9/13/2013||Curtis Crawford||Director||Sell||2,480||$26.95||$66,836.00|| |
|7/9/2013||Colin R Sabol||SVP||Sell||10,981||$28.67||$314,825.27|| |
|9/14/2012||Steven R Loranger||Director||Sell||72,300||$25.45||$1,840,035.00|| |
|9/12/2012||Steven R Loranger||Director||Sell||48,300||$25.18||$1,216,194.00|| |
|8/21/2012||Edward J Ludwig||Director||Buy||1,000||$25.60||$25,600.00|| |
Headline Trends for Xylem (NYSE:XYL)
Latest Headlines for Xylem (NYSE:XYL)
Xylem (XYL) Chart for Thursday, September, 21, 2017